Role of cyclic guanosine monophosphate and K+ channels as mediators of the mesenteric vascular hyporesponsiveness in portal hypertensive rats

Hepatology

Volumn 27, Issue 4, 1998, Pages 900-905

  Atucha, Noemí M ^a   Clara Ortiz M ^a   Fortepiani, Lourdes A ^a   Ruiz, Francisco M ^a   Martínez, Concepción ^a   García Estañ, Joaquín ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP; METHOXAMINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM ION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; LIVER DISEASE; MESENTERY BLOOD FLOW; NONHUMAN; PORTAL HYPERTENSION; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

ANIMALS; CYCLIC GMP; HYPERTENSION, PORTAL; MALE; MESENTERIC ARTERIES; METHOXAMINE; NITRIC OXIDE; POTASSIUM CHANNELS; RATS; RATS, SPRAGUE-DAWLEY; TETRAETHYLAMMONIUM COMPOUNDS;

EID: 17344374065     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510270402     Document Type: Article

References (17)

1. Vorobioff J, Bredfeldt JE, Groszmann RJ. Hyperdynamic circulation in portal hypertensive rat model: a primary factor for maintenance of chronic portal hypertension. Am J Physiol 1983;244:G52-G57.
2. Sikuler E, Kravetz D, Groszmann RJ. Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model. Am J Physiol 1985;248:G618-G625.
3. Murray BM, Paller MS. Pressor resistance to vasopressin in sodium depletion, potassium depletion and cirrhosis. Am J Physiol 1986;251: R525-R530.
4. Sitzmann JV, Li S-S, Lin P-W. Prostacyclin mediates splanchnic vascular response to norepinephrine in portal hypertension. J Surg Res 1989;47: 208-211.
5. Pizcueta MP, Casamitjana R, Bosch J, Rodés J. Decreased systemic vascular sensitivity to norepinephrine in portal hypertensive rats: role of hyperglucagonism. Am J Physiol 1990;258:G191-G195.
6. Murray BM, Paller MS. Decreased presser reactivity to angiotensin II in cirrhotic rats. Evidence for a post-receptor defect in angiotensin action. Circ Res 1985;57:424-431.
7. Lee F, Albillos A, Colombato LA, Groszmann RJ. The role of nitric oxide in the vascular hyporesponsiveness to methoxamine in portal hypertensive rats. HEPATOLOGY 1992;16:1043-1048.
8. Sieber CC, Groszmann RJ. In vitro hyporeactivity to methoxamine in portal hypertensive rats: reversal by nitric oxide blockade. Am J Physiol 1992;262:G996-G1001.
9. Castro A, Jiménez W, Clària J, Ros J, Martínez JM, Bosch M, Arroyo V, et al. Impaired responsiveness to angiotensin II in experimental cirrhosis: role of nitric oxide. HEPATOLOGY 1993;18:367-372.
10. Clària J, Jiménez W, Ros J, Rigol M, Angeli P, Arroyo V, Rivera F, et al. Increased nitric oxide-dependent vasorelaxation in aortic rings of cirrhotic rats with ascites. HEPATOLOGY 1994:20:1615-1621.
11. Ralevic V, Mathie RT, Moore KP, Burnstock G. Vasoconstrictor responsiveness of the rat mesenteric arterial bed in cirrhosis. Br J Pharmacol 1996;118:435-441.
12. Ortiz MC, Fortepiani LA, Martinez C, Atucha NM, Garcia-Esta J. Vascular hyporesponsiveness in aortic rings from cirrhotic rats: role of nitric oxide and endothelium. Clin Sci 1996;91:733-738.
13. Heinemann A, Stauber RE. Effect of terlipressin on in vitro vascular hyporeactivity of portal hypertensive rats. J Hepatol 1996;24:739-746.
14. Sieber CC, Lee F-Y, Groszmann RJ. Long-term octreotide treatment prevents vascular hyporeactivity in portal hypertensive rats. HEPATOLOGY 1996;23:1218-1223.
15. Atucha NM, Ortfz MC, Martinez C, Quesada T, Garcia-Esta J. Role of protein kinase C in mesenteric presser responses of rats with portal hypertension. Br J Pharmacol 1996;118:277-282.
16. Atucha NM, Shah V, Garcia-Cardea G, Sessa WE, Groszmann RJ. Role of endothelium in the abnormal response of mesenteric vessels in rats with portal hypertension and liver cirrhosis. Gastroenterology 1996;111: 1627-1632.
17. Mathie RT, Ralevic V, Moore KP, Burnstock G. Mesenteric vasodilator responses in cirrhotic rats: a role for nitric oxide? HEPATOLOGY 1996;23: 130-136.